Heide Siggelkow

3.1k total citations
90 papers, 2.0k citations indexed

About

Heide Siggelkow is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Heide Siggelkow has authored 90 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Surgery and 29 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Heide Siggelkow's work include Parathyroid Disorders and Treatments (19 papers), Thyroid and Parathyroid Surgery (18 papers) and Bone Metabolism and Diseases (18 papers). Heide Siggelkow is often cited by papers focused on Parathyroid Disorders and Treatments (19 papers), Thyroid and Parathyroid Surgery (18 papers) and Bone Metabolism and Diseases (18 papers). Heide Siggelkow collaborates with scholars based in Germany, Switzerland and United States. Heide Siggelkow's co-authors include Michael J. Atkinson, M. Hüfner, Volker Viereck, Norbert Schütze, Leticia Quintanilla‐Martinez, Karin Bink, Jochen Graw, Natalia S. Pellegata, Heinz Höfler and Falko Fend and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Heide Siggelkow

77 papers receiving 1.9k citations

Peers

Heide Siggelkow
Tobias Schilling Germany
David J. Rickard United States
Tetsuya Kawane Japan
Nagako Akeno United States
Dominique Modrowski France
Andrea Del Fattore Italy
Sanshiro Hashimoto United States
Lawrence B. Riggs United States
Laura Masi Italy
Gianna Galli Italy
Tobias Schilling Germany
Heide Siggelkow
Citations per year, relative to Heide Siggelkow Heide Siggelkow (= 1×) peers Tobias Schilling

Countries citing papers authored by Heide Siggelkow

Since Specialization
Citations

This map shows the geographic impact of Heide Siggelkow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heide Siggelkow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heide Siggelkow more than expected).

Fields of papers citing papers by Heide Siggelkow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heide Siggelkow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heide Siggelkow. The network helps show where Heide Siggelkow may publish in the future.

Co-authorship network of co-authors of Heide Siggelkow

This figure shows the co-authorship network connecting the top 25 collaborators of Heide Siggelkow. A scholar is included among the top collaborators of Heide Siggelkow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heide Siggelkow. Heide Siggelkow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertocchio, Jean‐Philippe, et al.. (2025). Adaptation and validation of the French version of the Hypoparathyroid Patient Questionnaire 28 (HPQ28) in the ComPaRe-Epi-Hypo e-cohort. JBMR Plus. 9(3). ziaf011–ziaf011. 1 indexed citations
2.
Cardoso, Luís, Lars Rolighed, Karin Amrein, et al.. (2025). Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disorders. European Journal of Endocrinology. 193(6). R65–R88.
3.
Grasemann, Corinna, Natasha M. Appelman‐Dijkstra, Adalbert Raimann, et al.. (2025). Transition Care for Young Persons with Rare Bone Mineral Conditions: A Consensus Recommendation from the ECTS Rare Bone Disease Action Group. Calcified Tissue International. 116(1). 73–73.
4.
Blaschke, Martina, Christina Heppner, Hans‐Peter Horny, et al.. (2025). The number of vertebral fractures in indolent systemic mastocytosis is influenced by presence of the KIT-mutation. Bone. 200. 117578–117578. 1 indexed citations
5.
Tsourdi, Elena, Karin Amrein, Christian Meier, et al.. (2025). Consensus-Based Recommendations for the Diagnosis, Treatment, and Monitoring of Hypoparathyroidism: Insights from the DACH Region. Calcified Tissue International. 116(1). 107–107.
6.
Siggelkow, Heide, et al.. (2025). German DVO risk score identified more patients requiring treatment compared to FRAX. Endocrine Connections. 14(5).
7.
Sinningen, Kathrin, et al.. (2024). Description of bone health in adolescents and young persons with Klinefelter syndrome – results from a pilot study. SHILAP Revista de lepidopterología. 11(1). 9–9.
8.
Grasemann, Corinna, Florian Barvencik, Heide Siggelkow, et al.. (2023). Praxisrelevante Aspekte zur biochemischen und molekulargenetischen Diagnostik bei seltenen Knochenerkrankungen – vom Netzwerk Seltene Osteopathien (NetsOs*). Osteologie/Osteology. 32(4). 270–277.
9.
10.
Sinningen, Kathrin, et al.. (2023). Cardiorespiratory fitness in adolescents and young adults with Klinefelter syndrome – a pilot study. Frontiers in Endocrinology. 14. 1106118–1106118. 3 indexed citations
11.
Bacchetta, Justine, Maria Luisa Brandi, Pablo Florenzano, et al.. (2020). An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia. Journal of Bone and Mineral Research. 37(1). 12–20. 18 indexed citations
12.
Blaschke, Martina, et al.. (2018). Crohn’s disease patient serum changes protein expression in a human mesenchymal stem cell model in a linear relationship to patients’ disease stage and to bone mineral density. Journal of Clinical & Translational Endocrinology. 13. 26–38. 7 indexed citations
13.
Tsourdi, Elena, et al.. (2018). Auswirkungen von Schilddrüsenfunktionsstörungen auf den Knochen. Der Internist. 59(7). 661–667. 5 indexed citations
14.
Sahlmann, C., et al.. (2012). Patienten mit Autoimmunthyroiditis – Prävalenz der gutartigen Lymphadenopathie. Nuklearmedizin - NuclearMedicine. 51(6). 223–227. 4 indexed citations
15.
Siggelkow, Heide, et al.. (2009). The use of confluence stages does not decrease the overall variability in primary human osteoblasts but can give additional information on differentiation in vitro. Experimental and Clinical Endocrinology & Diabetes. 106(3). 217–225. 3 indexed citations
16.
Hüfner, M. & Heide Siggelkow. (2008). Fluoridtherapie bei der Osteoporose: Wo stehen wir heute?*. DMW - Deutsche Medizinische Wochenschrift. 123(22). 713–717.
17.
Roth, Carolyn, Heide Siggelkow, Annette Grüters, M. Hüfner, & M. Lakomek. (2008). Neonataler Morbus Basedow bei Zwillingen einer Mutter mit schwerer T3-Hyperthyreose. DMW - Deutsche Medizinische Wochenschrift. 122(18). 572–577. 1 indexed citations
18.
Franke, Sybille, Heide Siggelkow, Günter Wolf, & Gert Hein. (2007). Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Archives of Physiology and Biochemistry. 113(3). 154–161. 102 indexed citations
19.
Pellegata, Natalia S., Leticia Quintanilla‐Martinez, Heide Siggelkow, et al.. (2006). Germ-line mutations in p27 Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proceedings of the National Academy of Sciences. 103(42). 15558–15563. 418 indexed citations
20.
Lechner, Andrew J., Norbert Schütze, Heide Siggelkow, Jochen Seufert, & Franz Jakob. (2000). The immediate early gene product hCYR61 localizes to the secretory pathway in human osteoblasts. Bone. 27(1). 53–60. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tobias Schilling Breakdown of academic impact, for papers by David J. Rickard Breakdown of academic impact, for papers by Tetsuya Kawane Breakdown of academic impact, for papers by Nagako Akeno Breakdown of academic impact, for papers by Dominique Modrowski Breakdown of academic impact, for papers by Andrea Del Fattore Breakdown of academic impact, for papers by Sanshiro Hashimoto Breakdown of academic impact, for papers by Lawrence B. Riggs Breakdown of academic impact, for papers by Laura Masi Breakdown of academic impact, for papers by Gianna Galli
Rankless by CCL
2026